Vanda Pharmaceuticals Inc(VNDA)
7.21
Change: -0.19 (▼ -2.63%)
As of Tue 12/20/2022 01:12 PM% Of Value
Growth
Value Per Share
:
:
:
500.00
8.27
4.7000 (as of 19/12/2022)
Fundamentals Data
| Open | 7.05 | Dividend | 37 |
| Close Price | 7.21 | DivYield | 0 % |
| High | 7.3299 | Growth | 20.5 M |
| Low | 7.01 | Growth% | 8.27 |
| P/e | 42.059 | Volume | 1.1 M |
| P/b | -0.96 | Market Capital | 395.7 M |
| Highest High | Lowest Low | ||
| 50 Days Moving Average | 10.12 (as of 21/12/2022) | 50 Days Moving Average Percentage | -40.319001386963 (as of 21/12/2022 |
| Industry: Major Pharmaceuticals |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 / 2017 | Year2 / 2018 | Year3 / 2019 | Year4 / 2020 | Current Year / 2021 |
| Revenue | 165.0 M | 193.1 M | 227.1 M | 248.1 M | 268.6 M |
| Cap Spending | -1.6 M | -25.3 M | -1.0 M | -1.7 M | -552,000.0 |
| Operating Expenses | 164.1 M | 150.8 M | 179.8 M | 197.5 M | 200.8 M |
| Operating Cash Flow | -16.9 M | 21.7 M | 22.8 M | 27.2 M | 42.1 M |
| Free Cash Flow | -3.6 M | 4.6 M | 44.9 M | 49.9 M | 63.6 M |
| Free Cash Flow Per Share | -0.082 | 0.091 | 0.846 | 0.918 | 1.146 |
| Total liabilities | 0.0 | 0.0 | 12.4 M | 11.4 M | 10.0 M |
| Total cash | 33.6 M | 61.0 M | 45.0 M | 61.0 M | 52.0 M |
| ROE% | -0.119 | 0.098 | 0.333 | 0.054 | 0.068 |
| Outstanding Shares | 45.4 M | 52.6 M | 53.6 M | 54.8 M | 55.9 M |
| P/E | -49.329 | 42.059 | 5.256 | 43.907 | 21.468 |
| P/S | 4.652 | 5.49 | 2.673 | 4.129 | 2.649 |
| Revenue USD | 165.0 M | 193.1 M | 227.1 M | 248.1 M | 268.6 M |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|